Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1981-6-13
pubmed:abstractText
Rabbit antibodies induced against alprenolol, a potent beta-adrenergic antagonist, bind to other antagonists, and, with less avidity, to catecholamine agonists. Anti-idiotypic antibodies were raised against the anti-alprenolol immunoglobulins. The anti-idiotypic antibodies specifically bind and agglutinate turkey erythrocytes; this is not observed for human agglutinate turkey erythrocytes; this is not observed for human or sheep erythrocytes, which are devoid of beta-adrenergic receptors. The anti-idiotypic antibodies compete with (--)-[3H]-dihydroalprenolol for binding on the beta-adrenergic receptors on purified turkey erythrocyte membranes. The binding to the membrane-bound receptors is prevented by preincubation of the anti-idiotypic antibodies with their immunogen, the antialprenolol immunoglobulins. The binding to the receptor is not merely passive: the anti-idiotypic antibodies stimulate basal adenylate cyclase activity [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] and enhance adenylate cyclase activation by catecholamine. These observations support the notion that antiidiotypic antibodies may constitute an "internal image" of the original antigen and may mimic its biological effects.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-13940767, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-14978855, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-170678, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-198798, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-220245, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-221503, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-270748, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-29641, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-303775, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-307766, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-36615, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-4142565, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-4827395, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-6153472, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-805681, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261254-988512
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7385-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't